16-1207298-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_021098.3(CACNA1H):c.2931C>T(p.Asn977Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000429 in 1,610,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00011   (  0   hom.,  cov: 30) 
 Exomes 𝑓:  0.000036   (  0   hom.  ) 
Consequence
 CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.367  
Publications
0 publications found 
Genes affected
 CACNA1H  (HGNC:1395):  (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008] 
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38). 
BP6
Variant 16-1207298-C-T is Benign according to our data. Variant chr16-1207298-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 529644.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.367 with no splicing effect.
BS2
High AC in GnomAd4 at 16 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.2892C>T | p.Asn964Asn | synonymous_variant | Exon 14 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.2892C>T | p.Asn964Asn | synonymous_variant | Exon 14 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*844C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2378C>T | non_coding_transcript_exon_variant | Exon 13 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*844C>T | 3_prime_UTR_variant | Exon 14 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2378C>T | 3_prime_UTR_variant | Exon 13 of 34 | ENSP00000518758.1 | 
Frequencies
GnomAD3 genomes  0.000105  AC: 16AN: 152040Hom.:  0  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
16
AN: 
152040
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000331  AC: 8AN: 241824 AF XY:  0.0000228   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
8
AN: 
241824
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000363  AC: 53AN: 1458110Hom.:  0  Cov.: 33 AF XY:  0.0000345  AC XY: 25AN XY: 725094 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
53
AN: 
1458110
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
25
AN XY: 
725094
show subpopulations 
African (AFR) 
 AF: 
AC: 
14
AN: 
33416
American (AMR) 
 AF: 
AC: 
1
AN: 
44288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26030
East Asian (EAS) 
 AF: 
AC: 
2
AN: 
39616
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
85758
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52578
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5760
European-Non Finnish (NFE) 
 AF: 
AC: 
31
AN: 
1110404
Other (OTH) 
 AF: 
AC: 
3
AN: 
60260
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 3 
 7 
 10 
 14 
 17 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000105  AC: 16AN: 152040Hom.:  0  Cov.: 30 AF XY:  0.0000943  AC XY: 7AN XY: 74252 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
16
AN: 
152040
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
7
AN XY: 
74252
show subpopulations 
African (AFR) 
 AF: 
AC: 
12
AN: 
41410
American (AMR) 
 AF: 
AC: 
0
AN: 
15272
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10608
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
314
European-Non Finnish (NFE) 
 AF: 
AC: 
4
AN: 
67988
Other (OTH) 
 AF: 
AC: 
0
AN: 
2090
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV    Benign:1 
Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV    Benign:1 
Feb 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.